A Modeling and Simulation Framework for Adverse Events in Erlotinib-Treated Non-Small-Cell Lung Cancer Patients

Overview of attention for article published in The AAPS Journal, August 2015

Altmetric Badge

Mentioned by

twitter: 1 X user

facebook: 1 Facebook page

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 33 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 1 X post from an account with 4,907 followers.

Modeling adverse events in erlotinib-treated non-small-cell #lungcancer patients – #AAPSJ http://t.co/bOGsZPumq1 http://t.co/81SXLXuA6j

Reply Repost Favourite